399
Participants
Start Date
March 31, 2020
Primary Completion Date
October 31, 2021
Study Completion Date
December 1, 2021
IFX-1 + BSC
Phase II study part: IFX-1 + BSC
BSC
Phase II study part: BSC
IFX-1 + SOC
Phase III study part: IFX-1 + SOC
Placebo + SOC
Phase III study part: Placebo + SOC
InflaRx Site #1107, Aalst
InflaRx Site #1102, Brussels
InflaRx Site #1104, Leuven
InflaRx Site #1106, Lodelinsart
InflaRx Site #1101, Yvoir
InflaRx Site #0301, Belo Horizonte
InflaRx Site #0302, Campinas
InflaRx Site #0305, Criciúma
InflaRx Site #0308, Curitiba
InflaRx Site #0304, Porto Alegre
InflaRx Site #0303, São José
InflaRx Site #0306, São Paulo
InflaRx Site #1011, Grenoble
InflaRx Site #1005, Nantes
InflaRx Site #1009, Nantes
InflaRx Site #1003, Nice
InflaRx Site #1001, Paris
InflaRx Site #1004, Paris
InflaRx Site #1006, Paris
InflaRx Site #1008, Paris
InflaRx Site #1012, Saint-Etienne
InflaRx Site #1002, Suresnes
InflaRx Site #0201, Aachen
InflaRx Site #0207, Augsburg
InflaRx Site #0202, Berlin
InflaRx Site #0208, Dresden
InflaRx Site #0204, Essen
InflaRx Site #0203, Greifswald
InflaRx Site #0205, Hanover
InflaRx Site #0206, Jena
InflaRx Site #0502, Chihuahua City
InflaRx Site #0503, Culiacán
InflaRx Site #0506, Mérida
InflaRx Site #0504, Monterrey
InflaRx Site #0501, Nuevo León
InflaRx Site #0505, Veracruz
InflaRx Site #0101, Amsterdam
InflaRx Site #0103, Amsterdam
InflaRx Site #0106, Eindhoven
InflaRx Site #0104, Enschede
InflaRx Site #0102, Maastricht
InflaRx Site #0601, Callao
InflaRx Site #0603, Lima
InflaRx Site #0604, Lima
InflaRx Site #0701, Barnaul
InflaRx Site #0704, Moscow
InflaRx Site #0702, Ryazan
InflaRx Site # 0804, Somerset West
Lead Sponsor
InflaRx GmbH
INDUSTRY